Risk of breast cancer death by current pre-diagnostic and post-diagnostic statin use within a cohort of all breast cancer patients diagnosed in Finland during 1995–2003.

Analysis stratified by propensity for post-diagnostic statin use, population characteristics at baseline and primary treatment selection.
aCalculated with Cox regression model adjusted for age, tumor stage and morphology and treatment selection.
bPropensity for post-diagnostic statin usage as a function of age, tumor stage and morphology, initial treatment choice and pre-diagnostic statin use.
Risk of breast cancer death by current pre-diagnostic and post-diagnostic statin use within a cohort of all breast cancer patients diagnosed in Finland during 1995–2003.